Back to search
Renal Insufficiency / Therapy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Renal Insufficiency / Therapy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Renal Insufficiency / Therapy trials you may qualify forThe purpose of the SPYRAL SWYFT sub-study is to evaluate whether renal denervation with the Symplicity Spyral system performed in the main and first order branc…
The investigators are conducting a study to see which program better helps older patients with kidney disease choose their treatment. Investigators are also inv…
This study in being conducted in men who have low testosterone and chronic kidney disease. The investigators will evaluate the effects of an oral testosterone p…
In the United States, the burden of chronic kidney disease (CKD) rests disproportionately on rural communities. This study evaluates the implementation and effe…
An estimated 10-15% of critically ill patients with acute kidney failure in the intensive care unit receive acute dialysis therapy. The majority of these patien…
Roxadustat is a licensed medicine to treat anemia in adults with chronic kidney disease (CKD). Anemia is a low level of red blood cells. Current treatment for a…
The purpose of this Ph2b study is to characterize the dose-response relationship and to evaluate the safety and efficacy of three different single doses of TIN8…
Hemodynamic management of critically ill patients has long been focused on the arterial side of the vasculature by assessing adequate perfusion pressure. Howeve…